HSPB1 and ovarian cancer: Moreover, J2 compound, an Hsp27 inhibitor, reduced the proliferation of human ovarian cancer cell lines (SKOV3 and OVCAR-3) by inducing apoptotic pathways through its interaction with HSP27 [52].